Search by Drug Name or NDC

    NDC 55292-0322-60 Isturisa 10 mg/1 Details

    Isturisa 10 mg/1

    Isturisa is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is OSILODROSTAT PHOSPHATE.

    Product Information

    NDC 55292-0322
    Product ID 55292-322_a135c232-1745-6ff6-e053-2a95a90acef1
    Associated GPIs 30022060600340
    GCN Sequence Number 080816
    GCN Sequence Number Description osilodrostat phosphate TABLET 10 MG ORAL
    HIC3 P1G
    HIC3 Description ADRENAL STEROID INHIBITORS
    GCN 47795
    HICL Sequence Number 046396
    HICL Sequence Number Description OSILODROSTAT PHOSPHATE
    Brand/Generic Brand
    Proprietary Name Isturisa
    Proprietary Name Suffix n/a
    Non-Proprietary Name Osilodrostat
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name OSILODROSTAT PHOSPHATE
    Labeler Name Recordati Rare Diseases, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212801
    Listing Certified Through 2022-12-31

    Package

    NDC 55292-0322-60 (55292032260)

    NDC Package Code 55292-322-60
    Billing NDC 55292032260
    Package 60 TABLET, COATED in 1 BLISTER PACK (55292-322-60)
    Marketing Start Date 2020-03-31
    NDC Exclude Flag N
    Pricing Information N/A